Left panels are overall survival and right panels are disease free survival after initial treatment A. ITPKB. Overall survival time for patients that do not harbor alterations in ITPKB is significantly longer than patients with alterations in ITPKB (log rank test P-Value: 5.5 × 10−4) (Cases with alteration in query gene: total cases: 12, deceased: 5, median months survival: 5.2, cases without alteration in query gene: total cases: 154, deceased: 98, median months survival: 20.5). Patients with ITPKB alterations had significantly lower disease free survival (log rank test P-Value: 0.01) (Cases with alteration in query gene: total cases: 12, deceased 5 median months survival 5.2, Cases without alteration in query gene: total cases: 152, deceased: 72, median months survival: 17). B. NBEAL2. The overall survival time for patients that do not harbor alteration in NBEAL2 is significantly longer than patients with alterations in NBEAL2 (log rank test P-Value: 0.004) (Cases with alteration in query gene: total cases: 8, deceased: 11, median months survival 11.8, cases without alteration in query gene: total cases: 154, deceased: 98, median months survival: 18.5). Effect of NBEAL2 alteration on disease free survival after initial treatment. Disease free survival was not significantly different for patients with or without NBEAL2 alterations (log rank test P-Value: 0.53) (Cases with alteration in query gene: total cases: 2, deceased: 1, median months survival: 8.2, cases without alteration in query gene: total cases: 162, deceased: 76, median months survival: 17). C. CCDC12. The overall survival time for patients that do not harbor alteration in CCDC12 is significantly longer than patients with alterations in CCDC12 (log rank test P-Value: 0.03) although there were few patients harboring this mutation in the 2013 TCGA cohort (Cases with alteration in query gene: total cases: 2, deceased: 2 median months survival: 0.8, cases without alteration in query gene: total cases: 164, deceased: 107, median months survival: 18.5). The disease free survival was not significantly different for patients with or without CCDC12 alterations (log rank test P-Value: 0.18) (Cases with alteration in query gene: total cases: 2, deceased: 1, median months survival: 8.2, cases without alteration in query gene: total cases: 162, deceased: 76, median months survival: 17).